X0206 3 2022-04-01 0 0001192448 GLAUKOS Corp GKOS 0001920053 Navratil Tomas C/O GLAUKOS CORPORATION 229 AVENIDA FABRICANTE SAN CLEMENTE CA 92672 0 1 0 0 Chief Development Officer Common Stock 37866 D Stock Option (Right to Buy) 55.00 2030-10-19 Common Stock 4181 D Stock Option (Right to Buy) 85.94 2031-03-18 Common Stock 8788 D Includes 35,971 restricted stock units that have not yet vested or been delivered to the Reporting Person. This option was granted on October 19, 2020 and has a four-year vesting schedule in which 25% vests on the first year anniversary of the grant date and the remainder vests in equal monthly installments for 36 months thereafter, such that the stock option vests in full on the four-year anniversary of the grant date. This option was granted on March 18, 2021 and has a four-year vesting schedule in which 25% vests on the first year anniversary of the grant date and the remainder vests in equal monthly installments for 36 months thereafter, such that the stock option vests in full on the four-year anniversary of the grant date. Diana Scherer, Attorney-in-Fact 2022-04-05

Exhibit 24

POWER OF ATTORNEY

FOR SEC FILINGS ON FORMS ID, 3, 4, 5 AND 144

IN RESPECT OF SECURITIES OF

GLAUKOS CORPORATION

The undersigned hereby constitutes and appoints each of Diane W. Biagianti, Senior Vice President, General Counsel of Glaukos Corporation (the "Company") and Diana A. Scherer, Vice President, Compliance, Deputy General Counsel & Corporate Secretary of the Company, so long as each is employed at the Company, and Regina Braman, of O'Melveny & Myers LLP ("OMM"), outside counsel to the Company, so long as she is employed at OMM, as the undersigned's true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution for the undersigned and in the undersigned's name and stead in any and all capacities, to sign and file for and on the undersigned’s behalf, in respect of any acquisition, disposition or other change in ownership of any securities of the Company, the following:

(i)

any Form ID to be filed with the Securities and Exchange Commission (the "SEC");

(ii)

any Initial Statement of Beneficial Ownership of Securities on Form 3 to be filed with the SEC;

(iii)

any Statement of Changes of Beneficial Ownership of Securities on Form 4 to be filed with the SEC;

(iv)

any Annual Statement of Beneficial Ownership of Securities on Form 5 to be filed with the SEC;

(v)

any Notice of Proposed Sale of Securities on Form 144 to be filed with the SEC; and

(vi)

any and all agreements, certificates, receipts, or other documents in connection therewith.

The undersigned hereby gives full power and authority to the attorney-in-fact to seek and obtain as the undersigned's representative and on the undersigned's behalf, information on transactions in the Company's securities from any third party, including brokers, employee benefit plan administrators and trustees, and the undersigned hereby authorizes any such person to release such information to the undersigned and approves and ratifies any such release of information.

The undersigned hereby grants unto such attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary in connection with such matters and hereby ratifies and confirms all that any such attorney-in-fact and agent or substitute may do or cause to be done by virtue hereof.

The undersigned acknowledges that:

(i)

neither the Company nor such attorney- in-fact assumes (i) any liability for the undersigned's responsibility to comply with the requirement of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), (ii) any liability of the undersigned for any failure to comply with such requirements or (iii) any obligation or liability of the undersigned for profit disgorgement under Section 16(b) of the Exchange Act; and

(ii)

this Power of Attorney does not relieve the undersigned from responsibility for compliance with the undersigned's obligations under the Exchange Act, including without limitation the reporting requirements under Section 16 of the Exchange Act.

This Power of Attorney shall remain in full force and effect until revoked by the undersigned in a signed writing delivered to such attorney-in- fact.

IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney.

Date: March 22, 2022

	/s/ Tomas Navratil
	Name: